Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents
Ruifeng Wang, Yixuan Chen, Xiangxin Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111716-111716
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Synthesis and biological activity of pyrimidines-containing hybrids: Focusing on pharmacological application
Elham Zarenezhad, Mojtaba Farjam, Aida Iraji
Journal of Molecular Structure (2021) Vol. 1230, pp. 129833-129833
Closed Access | Times Cited: 87
Pyrimidine: a review on anticancer activity with key emphasis on SAR
Aastha Mahapatra, Tanya Prasad, Tripti Sharma
Future Journal of Pharmaceutical Sciences (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 87
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
Yang Lu, Haiying Sun
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14382-14403
Closed Access | Times Cited: 72
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Xiaojing Pang, Xiujuan Liu, Yuan Liu, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4250-4250
Open Access | Times Cited: 57
The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 35
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 9
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression
Damiano Cosimo Rigiracciolo, Francesca Cirillo, Marianna Talia, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 645-645
Open Access | Times Cited: 42
Photocytotoxicity and photoinduced phosphine ligand exchange in a Ru(ii) polypyridyl complex
Sean J. Steinke, Sayak Gupta, Eric J. Piechota, et al.
Chemical Science (2022) Vol. 13, Iss. 7, pp. 1933-1945
Open Access | Times Cited: 34
Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors
Ruifeng Wang, Sijia Yu, Xiangxin Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 188, pp. 112024-112024
Closed Access | Times Cited: 46
Focal adhesion kinase: Insight into its roles and therapeutic potential in oesophageal cancer
Yumeng Zhang, Shu Liu, Shu Zhou, et al.
Cancer Letters (2020) Vol. 496, pp. 93-103
Closed Access | Times Cited: 44
Identification of Thieno[3,2-d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3
Hanna Cho, Injae Shin, Hojong Yoon, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 16, pp. 11934-11957
Closed Access | Times Cited: 23
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 8
FAK inhibitors in cancer, a patent review – an update on progress
Ya‐Xi Ye, Yuyao Cao, Lisheng Xu, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 593-610
Closed Access | Times Cited: 2
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study
Ruifeng Wang, Xiangxin Zhao, Sijia Yu, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104092-104092
Closed Access | Times Cited: 25
Discovery of novel pyrrolo [2,3-d] pyrimidine derivatives as potent FAK inhibitors based on cyclization strategy
Shenxin Zeng, Shuai Yuan, Yu Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106713-106713
Closed Access | Times Cited: 7
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer
Wei Wei, Zhanzhan Feng, Zhihao Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 113978-113978
Closed Access | Times Cited: 17
FAK Inhibitors As Promising Anticancer Targets: Present and Future Directions
Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia A Abdelhafeez, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 18, pp. 1559-1590
Open Access | Times Cited: 15
Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential
Yingnan Li, Yuming Zhang, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116913-116913
Closed Access | Times Cited: 1
Pyrrolo[2,3-d]pyrimidines as potential kinase inhibitors in cancer drug discovery: A critical review
Malyala Sai Madhurya, Vanashree Thakur, Sowmya Dastari, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107867-107867
Closed Access | Times Cited: 1
Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents
Ruifeng Wang, Ke Chen, S. Q. Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 114, pp. 117961-117961
Closed Access | Times Cited: 1
New Insights on Fak and Fak Inhibitors
Chiara Brullo, Bruno Tasso
Current Medicinal Chemistry (2020) Vol. 28, Iss. 17, pp. 3318-3338
Closed Access | Times Cited: 15
In silico design of novel FAK inhibitors using integrated molecular docking, 3D-QSAR and molecular dynamics simulation studies
Pouria Shirvani, Afshin Fassihi
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 13, pp. 5965-5982
Closed Access | Times Cited: 13
The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021
Ting Liang, Ying-Xiang Yang, Jiayun Wang, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 1118-1136
Closed Access | Times Cited: 4
Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live Cells
Xuan Yang, Jeffery L. Smith, Michael Beck, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 2950-2950
Open Access | Times Cited: 4
Design, synthesis, and cytotoxic activity of novel 2H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidine derivatives
Youguang Zheng, Xin Pei, Dexin Xia, et al.
Bioorganic Chemistry (2021) Vol. 109, pp. 104711-104711
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top